The assessment of olivocochlear function in neonates with real-time distortion product otoacoustic emissions

Laryngoscope

Volumn 121, Issue 1, 2011, Pages 202-213

  James, Adrian L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

auditory neuropathy; contralateral suppression; Level of Evidence: 2b.; Neonatal hearing test; olivocochlear; otoacoustic emission

Indexed keywords

ARTICLE; AUDIOMETRY; AUDITORY STIMULATION; AUDITORY THRESHOLD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COCHLEAR NERVE; COMPUTER ASSISTED TOMOGRAPHY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; HEARING DISORDER; HEARING TEST; HUMAN; HYPERBILIRUBINEMIA; IMAGE RECONSTRUCTION; LATENT PERIOD; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RISK FACTOR;

AUDITORY DISEASES, CENTRAL; AUDITORY PATHWAYS; COCHLEA; HEARING LOSS, SENSORINEURAL; HEARING TESTS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; OLIVARY NUCLEUS; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 78651069066     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21078     Document Type: Article

References (50)

1. Kennedy C, McCann D., Universal neonatal hearing screening moving from evidence to practice. Arch Dis Child Fetal Neonatal Ed 2004; 89: F378-F383.
2. Thompson DC, McPhillips H, Davis RL, et al. Universal newborn hearing screening: summary of evidence. JAMA 2001; 286: 2000-2010.
3. Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007; 120: 898-921.
4. Johnson JL, White KR, Widen JE, et al. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol. Pediatrics 2005; 116: 663-672.
5. Hayes D, Sininger YS., Guidelines for identification and management of infants and young children with auditory neuropathy spectrum disorder. In:, Northern J, ed. Guidelines Development Conference at NHS 2008. Aurora, CO: The Children's Hospital, Colorado; 2008: 3-8.
6. Buchman CA, Roush PA, Teagle HF, et al. Auditory neuropathy characteristics in children with cochlear nerve deficiency. Ear Hear 2006; 27: 399-408.
7. Yasunaga S, Grati M, Cohen-Salmon M, et al. A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat Genet 1999; 21: 363-369.
8. Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear 1999; 20: 238-252.
9. Amatuzzi MG, Northrop C, Liberman MC, et al. Selective inner hair cell loss in premature infants and cochlea pathological patterns from neonatal intensive care unit autopsies. Arch Otolaryngol Head Neck Surg 2001; 127: 629-636.
10. Sawada S, Mori N, Mount RJ, Harrison RV., Differential vulnerability of inner and outer hair cell systems to chronic mild hypoxia and glutamate ototoxicity: insights into the cause of auditory neuropathy. J Otolaryngol 2001; 30: 106-114.
11. Harrison RV, Sharma A, Brown T, Jiwani S, James AL., Amplitude modulation of DPOAEs by acoustic stimulation of the contralateral ear. Acta Otolaryngol 2008; 128: 404-407.
12. Hood LJ., A review of objective methods of evaluating auditory neural pathways. Laryngoscope 1999; 109: 1745-1748.
13. Hood LJ, Berlin CI., Auditory neuropathy (auditory dys-synchrony) disables efferent suppression of otoacoustic emissions. In:, Sininger YS, Starr A, eds. Auditory Neuropathy: A New Perspective on Hearing Disorders. San Diego, CA: Singular; 2001: 183-202.
14. Durante AS, Carvallo RM,. Contralateral suppression of linear and nonlinear transient evoked otoacoustic emissions in neonates at risk for hearing loss. J Commun Disord 2008; 41: 70-83.
15. Joint Committee on Infant Hearing. 1994 position statement. ASHA 1994; 36: 38-41.
16. Maisels MJ, Watchko JF., Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: F459-F463.
17. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
18. Mills DM., Origin and implications of two components in distortion product otoacoustic emissions. In:, Berlin CI, ed. Otoacoustic Emissions. San Diego, CA: Singular; 1998: 85-104.
19. Williams DM, Brown AM., The effect of contralateral broad-band noise on acoustic distortion products from the human ear. Hear Res 1997; 104: 127-146.
20. Morlet T, Collet L, Salle B, Morgon A., Functional maturation of cochlear active mechanisms and of the medial olivocochlear system in humans. Acta Otolaryngol 1993; 113: 271-277.
21. Durante AS, Carvalho RM., Contralateral suppression of otoacoustic emissions in neonates. Int J Audiol 2002; 41: 211-215.
22. Gkoritsa, E, Tsakanikos, M, Korres, S, et al. Transient otoacoustic emissions in the detection of olivocochlear bundle maturation. Int J Pediatr Otorhinolaryngol 2006; 70: 671-676.
23. Abdala C, Ma E, Sininger YS., Maturation of medial efferent system function in humans. J Acoust Soc Am 1999; 105: 2392-2402.
24. Young VW, Harrison R, Dolan A, Kunov H., Comparison of three distortion product otoacoustic emission devices. Can Acoust 2000; 28: 136-137.
25. Li X, Wodlinger H, Sokolov Y., A new method for measuring DPOAEs and ASSRs.
26. Prasher D, Ryan S, Luxon L., Contralateral suppression of transiently evoked otoacoustic emissions and neuro-otology. Br J Audiol 1994; 28: 247-254.
27. James AL, Harrison RV, Pienkowski M, Dajani HR, Mount RJ., Dynamics of real time DPOAE contralateral suppression in chinchillas and humans. Int J Audiol 2005; 44: 118-129.
28. Warren EHI, Liberman MC., Effects of contralateral sound on auditory-nerve responses. II. Dependence on stimulus variables. Hear Res 1989; 37: 105-121.
29. Murata K, Tanahashi T, Horikawa J, Funai H., Mechanical and neural interactions between binaurally applied sounds in cat cochlear nerve fibers. Neurosci Lett 1980; 18: 289-294.
30. Veuillet E, Collet L, Duclaux R., Effect of contralateral acoustic stimulation on active cochlear micromechanical properties in human subjects: dependence on stimulus variables. J Neurophysiol 1991; 65: 724-735.
31. Mott JB, Norton SJ, Neely ST, Warr WB., Changes in spontaneous otoacoustic emissions produced by acoustic stimulation of the contralateral ear. Hear Res 1989; 38: 229-242.
32. Lind O., Contralateral suppression of TEOAE. Attempts to find a latency. Br J Audiol 1994; 28: 219-225.
33. Maison S, Durrant J, Gallineau C, Micheyl C, Collet M., Delay and temporal integration in medial olivocochlear bundle activation in humans. Ear Hear 2001; 22: 65-74.
34. Abdala C, Sininger YS, Ekelid M, Zeng FG., Distortion product otoacoustic emission suppression tuning curves in human adults and neonates. Hear Res 1996; 98: 38-53.
35. Neumann J, Uppenkamp S, Kollmeier B., Detection of the acoustic reflex below 80 dB HL. Audiol Neurootol 1996; 1: 359-369.
36. Mazlan R, Kei J, Hickson L., Test-Retest Reliability of the Acoustic Stapedial Reflex Test in Healthy Neonates. Ear Hear 2009; 30: 295-301.
37. Collet L, Kemp DT, Veuillet E, et al. Effect of contralateral auditory stimuli on active cochlear micro-mechanical properties in human subjects. Hear Res 1990; 43: 251-261.
38. Moulin A, Collet L, Duclaux R., Contralateral auditory stimulation alters acoustic distortion products in humans. Hear Res 1993; 65: 193-210.
39. Buki B, Wit HP, Avan P., Olivocochlear efferent vs. middle-ear contributions to the alteration of otoacoustic emissions by contralateral noise. Brain Res 2000; 852: 140-150.
40. Sun XM., Contralateral suppression of distortion product otoacoustic emissions and the middle-ear muscle reflex in human ears. Hear Res 2008; 237: 66-75.
41. Goodman SS, Keefe DH., Simultaneous measurement of noise-activated middle-ear muscle reflex and stimulus frequency otoacoustic emissions. J Assoc Res Otolaryngol 2006; 7: 125-139.
42. Berg AL, Spitzer JB, Towers HM, Bartosiewicz C, Diamond BE., Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Pediatrics 2005; 116: 933-938.
43. Berlin CI, Hood LJ, Cecola RP, Jackson DF, Szabo P., Does type I afferent neuron dysfunction reveal itself through lack of efferent suppression? Hear Res 1993; 65: 40-50.
44. Riga M, Psarommatis I, Korres S, et al. Neurotoxicity of vincristine on the medial olivocochlear bundle. Int J Pediatr Otorhinolaryngol 2007; 71: 63-69.
45. Shapiro SM, Bhutani VK, Johnson L., Hyperbilrubinaemia and kernicterus. Clin Perinatol 2006; 33: 387-410.
46. Jiang ZD, Chen C, Liu TT, Wilkinson AR., Changes in brainstem auditory evoked response latencies in term neonates with hyperbilirubinemia. Pediatr Neurol 2007; 37: 35-41.
47. Watchko JF., Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med 2006; 8: 513-529.
48. Durrant JD., Contralateral suppression of otoacoustic emissions-delay of effect? J Commun Disord 1998; 31: 485-488; 553.
49. Attias J, Raveh E., Transient deafness in young candidates for cochlear implants. Audiol Neurootol 2007; 12: 325-333.
50. Rance G, Barker EJ., Speech perception in children with auditory neuropathy/dyssynchrony managed with either hearing AIDS or cochlear implants. Otol Neurotol 2008; 29: 179-182.